Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Greater understanding of the complex host responses induced by type 1 interferon (IFN) cytokines could allow new therapeutic approaches for diseases in which these cytokines are implicated. We found that in response to the Toll-like receptor-9 agonist CpGA, plasmacytoid dendritic cells (pDC) produced type 1 IFNs, which, through an autocrine type 1 IFN receptor-dependent pathway, induced changes in cellular metabolism characterized by increased fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS). Direct inhibition of FAO and of pathways that support this process, such as fatty acid synthesis, prevented full pDC activation. Type 1 IFNs also induced increased FAO and OXPHOS in non-hematopoietic cells and were found to be responsible for increased FAO and OXPHOS in virus-infected cells. Increased FAO and OXPHOS in response to type 1 IFNs was regulated by PPARα. Our findings reveal FAO, OXPHOS and PPARα as potential targets to therapeutically modulate downstream effects of type 1 IFNs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695232 | PMC |
| http://dx.doi.org/10.1016/j.immuni.2016.06.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Organelle stresses and energetic metabolisms promote endothelial-to-mesenchymal transition and fibrosis via upregulating FOSB and MEOX1 in Alzheimer's disease.
Front Mol Neurosci
August 2025
Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Lemole Center for Integrated Lymphatics and Vascular Research, Temple University, Philadelphia, PA, United States.
Introduction: Endothelial-to-mesenchymal transition (EndoMT), cell death, and fibrosis are increasingly recognized as contributing factors to Alzheimer's disease (AD) pathology, but the underlying transcriptomic mechanisms remain poorly defined. This study aims to elucidate transcriptomic changes associated with EndoMT, diverse cell death pathways, and fibrosis in AD using the 3xTg-AD mouse model.
Methods: Using RNA-seq data and knowledge-based transcriptomic analysis on brain tissues from the 3xTg-AD mouse model of AD.
Teriflunomide Inhibits Human FOXP3 Regulatory T Cell Function by Interference With Mitochondrial Respiration.
Eur J Immunol
July 2025
Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC), Hasselt University, Diepenbeek, Belgium.
Regulatory FOXP3 T cells (Tregs) have been characterized with unique metabolic demands, preferentially relying on fatty acid β-oxidation (FAO) and oxidative phosphorylation (OXPHOS). Several studies have indicated that Treg mitochondrial fitness is crucial for maintaining their stability and suppressive activity with an emphasis on complex-III of the electron transport chain (ETC). Dysfunctional Tregs isolated from patients with autoimmunity like multiple sclerosis (MS) show diminished mitochondrial respiration and the induction of a T helper (Th)1-like phenotype, characterized by increased production of interferon (IFN)-γ.
View Article and Find Full Text PDFIntracellular Glutathione Cleaved Long-Targeting Chains of Cancer Cells and Macrophages to Exposedly Activate Mitochondria Delivery of Liposomes for Enhancing Antitumor Efficacy by Metabolic Reprogramming.
ACS Appl Mater Interfaces
September 2025
Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China.
Considering that M2-tumor associated macrophages (TAMs) performing immunosuppressive function in tumor microenvironment (TME) rely on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO) metabolic pathways for energy supply, whereas M1 TAMs with antitumor effect and cancer cells mainly rely on glycolysis as energy source, so targeting the vital subcellular organelles of mitochondria for metabolic reprogramming of TAMs and cancer cells by nanocarriers could be expected as promising approaches for enhancing antitumor efficacy. Herein, two kinds of liposomes with M2 TAMs/mitochondria-targeting co-delivered the OXPHOS inhibitor atractyloside (ATR) and curcumin (CUR) for lipid intervention (MST@A/C), and tumor/mitochondria-targeting liposomes encapsulated 2-DG (BST@2-DG) were fabricated. MST@A/C located in mitochondria of M2 TAMs could inhibit OXPHOS and lipid uptake by downregulating CD36 expression, killing M2 TAMs and induced the transformation of M2 to M1 TAMs.
View Article and Find Full Text PDFBioenergetic profiles and respiratory control in mitochondrial physiology: Precision analysis of oxidative phosphorylation.
Exp Physiol
August 2025
Oroboros Instruments, Innsbruck, Austria.
Oxidative phosphorylation (OXPHOS) is fundamental to mitochondrial function. Respirometry with living cells provides limited information compared to precision OXPHOS analysis with mitochondrial preparations, including isolated mitochondria, tissue homogenates, permeabilized tissues, and permeabilized cells. We studied mouse mitochondria from brain, a glucose-dependent tissue, and from heart, which relies highly on fatty acid oxidation (FAO).
View Article and Find Full Text PDFBupi Yishen formula improves chronic kidney disease by restoring renal energy metabolism and mitochondrial oxidative phosphorylation.
Phytomedicine
September 2025
State Key Laboratory of Traditional Chinese Medicine Syndrome/Department of Nephrology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, No. 55 Neihuan West Road, G
Background: Bupi Yishen formula (BYF) is a traditional Chinese herbal mixture with proven efficacy in attenuating kidney function deterioration among patients with advanced chronic kidney disease (CKD), and improving renal fibrosis of CKD animal models. Previous studies have shown that BYF rehabilitates metabolic dysregulation under CKD condition, but its exact mechanism remains unclear.
Purpose: This study aimed to elucidate the therapeutic effect and its potential mechanism on regulating renal energy metabolism in CKD.